These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26005037)

  • 21. Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection.
    Crawford S; Bath N
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S75-9. PubMed ID: 23884070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reclaiming joy: pilot evaluation of a mental health peer support program for older adults who receive Medicaid.
    Chapin RK; Sergeant JF; Landry S; Leedahl SN; Rachlin R; Koenig T; Graham A
    Gerontologist; 2013 Apr; 53(2):345-52. PubMed ID: 22936540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs.
    Munoz-Plaza CE; Strauss SM; Astone-Twerwll JM; Des Jarlais DC; Hagan H
    J Psychoactive Drugs; 2006 Sep; 38(3):233-41. PubMed ID: 17165366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia.
    Treloar C; Rance J; Grebely J; Dore GJ
    Drug Alcohol Depend; 2013 Dec; 133(2):529-34. PubMed ID: 23932843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Descriptive Analysis of a Community Clinic Providing Hepatitis C Treatment to Poor and Uninsured Patients.
    Sims OT; Melton PA; Ji S
    J Community Health; 2018 Aug; 43(4):725-730. PubMed ID: 29511988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and 10-year follow-up of a community-based hepatitis C cohort.
    Yawn BP; Wollan P; Gazzuola L; Kim WR
    J Fam Pract; 2002 Feb; 51(2):135-40. PubMed ID: 11978211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting.
    Treloar C; Rance J;
    Int J Drug Policy; 2014 Sep; 25(5):865-70. PubMed ID: 24559604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort.
    Braitstein P; Montessori V; Chan K; Montaner JS; Schechter MT; O'Shaughnessy MV; Hogg RS
    AIDS Care; 2005 May; 17(4):505-15. PubMed ID: 16036236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Australian men's experiences of living with hepatitis C virus: results from a cross-sectional survey.
    Gifford SM; O'Brien ML; Smith A; Temple-Smith M; Stoové M; Mitchell D; Jolley D
    J Gastroenterol Hepatol; 2005 Jan; 20(1):79-86. PubMed ID: 15610451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low rates of hepatitis C testing among people who inject drugs in Thailand: implications for peer-based interventions.
    Ti L; Kaplan K; Hayashi K; Suwannawong P; Wood E; Kerr T
    J Public Health (Oxf); 2013 Dec; 35(4):578-84. PubMed ID: 23335599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linkage to hepatitis C care after incarceration in jail: a prospective, single arm clinical trial.
    Akiyama MJ; Columbus D; MacDonald R; Jordan AO; Schwartz J; Litwin AH; Eckhardt B; Carmody E
    BMC Infect Dis; 2019 Aug; 19(1):703. PubMed ID: 31395019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.
    Alavi M; Grebely J; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ;
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S62-9. PubMed ID: 23884068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents.
    Alavi M; Raffa JD; Deans GD; Lai C; Krajden M; Dore GJ; Tyndall MW; Grebely J
    Liver Int; 2014 Sep; 34(8):1198-206. PubMed ID: 24164865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Content, participants and outcomes of three diabetes care programmes in three low and middle income countries.
    Van Olmen J; Marie KG; Christian D; Clovis KJ; Emery B; Maurits VP; Heang H; Kristien VA; Natalie E; François S; Guy K
    Prim Care Diabetes; 2015 Jun; 9(3):196-202. PubMed ID: 25281167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can a rural community-based work-related activity program make a difference for chronic pain-disabled injured workers?
    Dunstan DA; Covic T
    Aust J Rural Health; 2007 Jun; 15(3):166-71. PubMed ID: 17542788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A piece of the jigsaw of primary care: health professional perceptions of an integrated care model of hepatitis C management in the community.
    Treloar C; Gray R; Brener L
    J Prim Health Care; 2014 Jun; 6(2):129-34. PubMed ID: 24892130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Benefits of a preventive psychiatric accompaniment in patients Hepatitis C Virus seropositive (HCV): prospective study concerning 39 patients].
    Lang JP; Meyer N; Doffoel M
    Encephale; 2003; 29(4 Pt 1):362-5. PubMed ID: 14615706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam.
    Grady BP; Vanhommerig JW; Schinkel J; Weegink CJ; Bruisten SM; Lindenburg CE; Prins M
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1302-7. PubMed ID: 22825643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of injecting drug use status on hepatitis C-related referral and treatment.
    Stoové MA; Gifford SM; Dore GJ
    Drug Alcohol Depend; 2005 Jan; 77(1):81-6. PubMed ID: 15607844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial.
    Groessl EJ; Sklar M; Cheung RC; Bräu N; Ho SB
    Contemp Clin Trials; 2013 Jul; 35(2):97-107. PubMed ID: 23669414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.